Kailera Therapeutics
Kailera Therapeutics is a clinical-stage biopharmaceutical company developing therapeutic pipelines for obesity and type 2 diabetes. The pipeline includes injectable and oral peptides, such as GLP-1/GIP and GLP-1/GIP/Glucagon receptor agonists. Kailera Therapeutics licenses its therapies and conducts clinical trials focused on delivering treatment options for chronic weight management.
Domain
kailera.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$600.0M
Founded
2023
Tech Stack (24 technologies)
Frequently Asked Questions
What technologies does Kailera Therapeutics use?+
Kailera Therapeutics uses 24 technologies including Divi, Font Awesome, Google Analytics.
What industry is Kailera Therapeutics in?+
Kailera Therapeutics operates in the Biotechnology industry.
Where is Kailera Therapeutics based?+
Kailera Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026